The proportions of CD3+CD4+CD161+ and CD3+CD8+CD161+ T cells were compared according to the occurrence of mucositis (≥grade 3), infection before engraftment, and CMV reactivation (Figure 1). This evidence concerns the gene CD4 and mucositis.